Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Daniel V T Catenacci et al.   LANCET ONCOLOGY

Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges

(2017) Conor A. Bradley et al.   Nature Reviews Clinical Oncology

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma

(2017) Eleanna Papa et al.   Cell Death & Disease

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

(2017) Eirini Pectasides et al.   Cancer Discovery

Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification

(2017) Juan Du et al.   Oncotarget

Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma

(2017) Manish A. Shah et al.   JAMA Oncology

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types

(2017) Yongqian Shu et al.   Scientific Reports

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety

(2016) Yukiya Narita et al.   Expert Opinion On Drug Safety

Gastric cancer

(2016) Eric Van Cutsem et al.   LANCET

ATM Mutations in Cancer: Therapeutic Implications

(2016) M. Choi et al.   MOLECULAR CANCER THERAPEUTICS

Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites

(2016) Byungho Lim et al.   Oncotarget

Apatinib for the treatment of gastric cancer

(2016) Giandomenico Roviello et al.   Expert Review of Gastroenterology & Hepatology

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

(2015) Yung-Jue Bang et al.   JOURNAL OF CLINICAL ONCOLOGY

Tie2/TEK Modulates the Interaction of Glioma and Brain Tumor Stem Cells with Endothelial Cells and Promotes an Invasive Phenotype

(2015)   Oncotarget

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition

(2010) Simona Corso et al.   Molecular Cancer